X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3991) 3991
Book Review (814) 814
Publication (115) 115
Magazine Article (13) 13
Book / eBook (6) 6
Book Chapter (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3679) 3679
humans (3447) 3447
anti-ulcer agents - therapeutic use (2274) 2274
male (2202) 2202
female (1920) 1920
anti-ulcer agents - adverse effects (1483) 1483
middle aged (1455) 1455
adult (1309) 1309
aged (1164) 1164
gastroenterology & hepatology (1006) 1006
anti-ulcer agents - administration & dosage (965) 965
pharmacology & pharmacy (840) 840
anti-inflammatory agents, non-steroidal - adverse effects (825) 825
proton pump inhibitors (799) 799
omeprazole (790) 790
helicobacter infections - drug therapy (726) 726
animals (690) 690
helicobacter pylori (678) 678
treatment outcome (656) 656
omeprazole - therapeutic use (653) 653
anti-ulcer agents - pharmacology (636) 636
drug therapy, combination (613) 613
abridged index medicus (574) 574
omeprazole - adverse effects (549) 549
rats (486) 486
double-blind method (459) 459
lansoprazole (459) 459
peptic ulcer - drug therapy (455) 455
2-pyridinylmethylsulfinylbenzimidazoles (453) 453
stomach ulcer - drug therapy (452) 452
risk factors (428) 428
stomach ulcer - chemically induced (418) 418
omeprazole - analogs & derivatives (409) 409
adolescent (383) 383
omeprazole - administration & dosage (374) 374
gastric mucosa - drug effects (357) 357
anti-bacterial agents - therapeutic use (348) 348
gastroesophageal reflux - drug therapy (342) 342
aged, 80 and over (336) 336
dose-response relationship, drug (329) 329
duodenal ulcer - drug therapy (329) 329
stomach ulcer - prevention & control (324) 324
prospective studies (322) 322
medicine, general & internal (316) 316
histamine h2 antagonists - therapeutic use (288) 288
helicobacter pylori - drug effects (285) 285
time factors (280) 280
nonsteroidal antiinflammatory drugs (278) 278
peptic ulcer - chemically induced (270) 270
ranitidine (267) 267
peptic ulcer - prevention & control (264) 264
double-blind (252) 252
infection (252) 252
drug administration schedule (249) 249
medicine & public health (248) 248
helicobacter infections - complications (247) 247
gastric acid - secretion (234) 234
therapy (234) 234
gastric mucosa - pathology (231) 231
recurrence (228) 228
ulcers (224) 224
misoprostol (219) 219
prevention (219) 219
ranitidine - therapeutic use (219) 219
amoxicillin - therapeutic use (215) 215
anti-bacterial agents - adverse effects (213) 213
anti-bacterial agents - administration & dosage (210) 210
clinical trials as topic (207) 207
drug interactions (207) 207
peptic ulcer (204) 204
proton pump inhibitor (204) 204
eradication (203) 203
aspirin - adverse effects (201) 201
efficacy (200) 200
rats, wistar (194) 194
anti-inflammatory agents, non-steroidal - therapeutic use (190) 190
clarithromycin - therapeutic use (188) 188
drug therapy (188) 188
anti-ulcer agents - pharmacokinetics (187) 187
amoxicillin (186) 186
duodenal-ulcer (181) 181
risk (180) 180
disease (179) 179
rabeprazole (178) 178
administration, oral (176) 176
proton pump inhibitors - therapeutic use (176) 176
gastroenterology (172) 172
misoprostol - therapeutic use (170) 170
amoxicillin - administration & dosage (168) 168
analysis (167) 167
follow-up studies (167) 167
mice (166) 166
management (165) 165
clarithromycin (162) 162
triple therapy (161) 161
stomach ulcer - pathology (160) 160
care and treatment (154) 154
helicobacter infections - microbiology (153) 153
helicobacter-pylori infection (151) 151
oncology (151) 151
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3348) 3348
Japanese (199) 199
German (149) 149
French (68) 68
Spanish (64) 64
Russian (60) 60
Chinese (26) 26
Dutch (17) 17
Italian (17) 17
Danish (12) 12
Swedish (10) 10
Korean (8) 8
Norwegian (7) 7
Bulgarian (4) 4
Polish (4) 4
Romanian (4) 4
Czech (3) 3
Portuguese (3) 3
Ukrainian (3) 3
Hebrew (2) 2
Hungarian (2) 2
Croatian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 905 - 913
Journal Article
JAMA, ISSN 0098-7484, 05/2011, Volume 305, Issue 19, pp. 1969 - 1977
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2009, Volume 53, Issue 3, pp. 958 - 966
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CELL TRANSPLANT RECIPIENTS | STEADY-STATE PHARMACOKINETICS | BEVERAGE COCA-COLA | SALVAGE THERAPY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | FOOD INTERACTION | INVASIVE FUNGAL-INFECTION | ITRACONAZOLE | TRIAZOLE ANTIFUNGAL | VERSUS-HOST-DISEASE | FLUCONAZOLE | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Triazoles - blood | Area Under Curve | Humans | Middle Aged | Omeprazole - blood | Intestinal Absorption - drug effects | Male | Anti-Ulcer Agents - blood | Gastric Mucosa - metabolism | Anti-Ulcer Agents - pharmacokinetics | Dose-Response Relationship, Drug | Young Adult | Antifungal Agents - pharmacokinetics | Hydrogen-Ion Concentration - drug effects | Gastric Mucosa - drug effects | Adult | Female | Triazoles - pharmacokinetics | Suspensions | Eating | European Continental Ancestry Group - genetics | Fasting | Drug Administration Schedule | Administration, Oral | Food-Drug Interactions | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | African Americans - genetics | European Continental Ancestry Group - statistics & numerical data | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Carbonated Beverages | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | African Americans - statistics & numerical data | Antifungal Agents - administration & dosage | Antifungal Agents - blood | Index Medicus | Pharmacology
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9573, pp. 1621 - 1626
Summary Background Guidelines on pain management recommend that patients at risk of ulcers receive either a cyclo-oxygenase (COX 2) inhibitor or a... 
Internal Medicine | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | NSAID | CYCLOOXYGENASE-2 INHIBITORS | ARTHRITIS PATIENTS | NAPROXEN | COMPLICATIONS | HELICOBACTER-PYLORI | PEPTIC-ULCER | CELECOXIB | Pyrazoles - therapeutic use | Humans | Esomeprazole - adverse effects | Male | Secondary Prevention | Osteoarthritis - drug therapy | Esomeprazole - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Female | Drug Therapy, Combination | Pyrazoles - adverse effects | Anti-Ulcer Agents - therapeutic use | Double-Blind Method | Proton Pump Inhibitors | Risk Factors | Anti-Ulcer Agents - adverse effects | Peptic Ulcer Hemorrhage - chemically induced | Treatment Outcome | Celecoxib | Peptic Ulcer Hemorrhage - therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Sulfonamides - adverse effects | Aged | Cyclooxygenase Inhibitors - adverse effects | Cyclooxygenase Inhibitors - therapeutic use | Prevention | Complications and side effects | COX-2 inhibitors | Relapse | Gastrointestinal bleeding | Peptic ulcer | Proton pump inhibitors | Dosage and administration | Drug therapy | Diseases | Drugs | Medical research | Physical examinations | Hospitals | Analgesics | Ulcers | Terminal illnesses | Clinical trials | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 07/2014, Volume 40, Issue 2, pp. 171 - 177
Journal Article
Gastroenterology, ISSN 0016-5085, 2007, Volume 132, Issue 2, pp. 498 - 506
Background & Aims: Traditional nonaspirin, nonsteroidal anti-inflammatory drugs (tNSAIDs) have been associated with a 3- to 5-fold increased risk in upper... 
Gastroenterology and Hepatology | SELECTIVE CYCLO-OXYGENASE-2 INHIBITORS | VARIABILITY | TRIALS | METAANALYSIS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | HEMORRHAGE | ULCER | ROFECOXIB | NAPROXEN | ARTHRITIS | GASTROENTEROLOGY & HEPATOLOGY | Humans | Peptic Ulcer Perforation - chemically induced | Half-Life | Warfarin - adverse effects | Duodenal Ulcer - chemically induced | Case-Control Studies | Dose-Response Relationship, Drug | Cyclooxygenase 2 Inhibitors - adverse effects | Peptic Ulcer Perforation - epidemiology | Drug Interactions | Time Factors | Aspirin - adverse effects | Duodenal Ulcer - epidemiology | Retrospective Studies | Steroids - adverse effects | Stomach Ulcer - chemically induced | Risk Assessment | Cyclooxygenase 2 Inhibitors - administration & dosage | Risk Factors | Anti-Ulcer Agents - adverse effects | Peptic Ulcer Hemorrhage - chemically induced | Anticoagulants - adverse effects | Cyclooxygenase 2 Inhibitors - pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Delayed-Action Preparations - adverse effects | Stomach Ulcer - epidemiology | Upper Gastrointestinal Tract - drug effects | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Peptic Ulcer Hemorrhage - epidemiology | United Kingdom - epidemiology | Gastrointestinal Diseases - chemically induced | Cohort Studies | Complications and side effects | Nonsteroidal anti-inflammatory drugs | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 6, pp. 1158 - 1165
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 02/2014, Volume 348, Issue 2, pp. 227 - 235
Antisecretory drugs such as histamine H-2-receptor antagonists and proton pump inhibitors are commonly used for the treatment of upper gastrointestinal mucosal... 
2,4-DIAMINO-6-(2,5-DICHLOROPHENYL)-S-TRIAZINE MALEATE MN-1695 | GASTROINTESTINAL SYMPTOMS | REBAMIPIDE | NONSTEROIDAL ANTIINFLAMMATORY DRUG | SMALL-BOWEL INJURY | DIETARY FIBER | PHARMACOLOGY & PHARMACY | MECHANISMS | PEPTIC-ULCERS | IRSOGLADINE MALEATE | DAMAGE | Intestinal Diseases - prevention & control | Alanine - therapeutic use | Intestinal Diseases - chemically induced | Intestine, Small - pathology | Rats, Wistar | Triazines - therapeutic use | Misoprostol - administration & dosage | Gastrointestinal Agents - administration & dosage | Intestinal Mucosa - secretion | Male | Mucus - drug effects | Protective Agents - therapeutic use | Intestinal Mucosa - drug effects | Gastric Mucins - therapeutic use | Dose-Response Relationship, Drug | Alanine - analogs & derivatives | Alanine - administration & dosage | Gastric Mucins - administration & dosage | Quinolones - therapeutic use | Ranitidine - adverse effects | Ranitidine - therapeutic use | Anti-Ulcer Agents - therapeutic use | Proton Pump Inhibitors - adverse effects | Omeprazole - therapeutic use | Diclofenac - adverse effects | Anti-Ulcer Agents - adverse effects | Rats | Mucus - secretion | Omeprazole - adverse effects | Proton Pump Inhibitors - therapeutic use | Intestine, Small - secretion | Quinolones - administration & dosage | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Triazines - administration & dosage | Intestine, Small - drug effects | Gastrointestinal Agents - therapeutic use | Protective Agents - administration & dosage | Sus scrofa | Intestinal Diseases - pathology | Intestinal Mucosa - pathology | Misoprostol - therapeutic use | Index Medicus
Journal Article
Helicobacter, ISSN 1083-4389, 04/2013, Volume 18, Issue 2, pp. 129 - 134
Background The eradication of Helicobacter pylori has been always a concern. In the present study, we aimed to compare two novel treatments in Iran. Method... 
hybrid | clarithromycin | sequential | ran | elicobacter pylor | Hybrid | Clarithromycin | Helicobacter pylori | Iran | Sequential | METAANALYSIS | EFFICACY | PROTON-PUMP INHIBITOR | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | AMOXICILLIN | REGIMENS | TRIPLE THERAPY | INFECTION | 1ST-LINE | GASTROENTEROLOGY & HEPATOLOGY | Prospective Studies | Humans | Middle Aged | Tinidazole - adverse effects | Helicobacter pylori - drug effects | Male | Tinidazole - therapeutic use | Anti-Bacterial Agents - therapeutic use | Peptic Ulcer - microbiology | 2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Anti-Ulcer Agents - therapeutic use | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Clarithromycin - adverse effects | Anti-Ulcer Agents - adverse effects | Treatment Outcome | Clarithromycin - therapeutic use | Anti-Ulcer Agents - administration & dosage | Tinidazole - administration & dosage | Amoxicillin - therapeutic use | Amoxicillin - adverse effects | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Helicobacter Infections - microbiology | Urea | Care and treatment | Amoxicillin | Clinical trials | Helicobacter infections | Comparative analysis | Antiulcer drugs | Index Medicus
Journal Article
Helicobacter, ISSN 1083-4389, 06/2013, Volume 18, Issue 3, pp. 180 - 186
Background The eradication rate with PPI-based standard triple therapy for Helicobacter pylori infection has fallen considerably. One recent innovation is... 
quadruple | concomitant | Helicobacter pylori | eradication | sequential | Quadruple | Sequential | Eradication | Concomitant | METAANALYSIS | MANAGEMENT | CONSENSUS CONFERENCE | CLARITHROMYCIN RESISTANCE | REGIMEN | MICROBIOLOGY | KOREA | TRIAL | QUADRUPLE THERAPY | TRIPLE THERAPY | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Proton Pump Inhibitors - pharmacology | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Rabeprazole | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Metronidazole - therapeutic use | 2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Anti-Ulcer Agents - pharmacology | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Anti-Ulcer Agents - therapeutic use | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Breath Tests | Treatment Outcome | Proton Pump Inhibitors - therapeutic use | Pilot Projects | Urea - therapeutic use | Amoxicillin - therapeutic use | Amoxicillin - adverse effects | Aged | Anti-Bacterial Agents - pharmacology | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Anti-Bacterial Agents - administration & dosage | Helicobacter Infections - microbiology | Urea | Care and treatment | Patient outcomes | Amoxicillin | Helicobacter infections | Index Medicus
Journal Article